R. Andrew Clyde - 12 Feb 2025 Form 4 Insider Report for Murphy USA Inc. (MUSA)

Role
President & CEO, Director
Signature
/s/ Gregory L. Smith, attorney-in-fact
Issuer symbol
MUSA
Transactions as of
12 Feb 2025
Net transactions value
$0
Form type
4
Filing time
14 Feb 2025, 16:21:38 UTC
Previous filing
10 Feb 2025
Next filing
25 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MUSA Common Stock Options Exercise $0 +29,608 +15% $0.000000 233,670 12 Feb 2025 Direct F1
transaction MUSA Common Stock Tax liability $0 -12,806 -5.5% $0.000000 220,864 12 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MUSA Stock Option Award $0 +12,200 $0.000000 12,200 12 Feb 2025 Common Stock 12,200 $492.22 Direct F3, F4
transaction MUSA Restricted Stock Unit Award $0 +3,850 +37% $0.000000 14,350 12 Feb 2025 Common Stock 3,850 Direct F3, F5
transaction MUSA Performance Stock Unit Award $0 +7,700 +22% $0.000000 43,300 12 Feb 2025 Common Stock 7,700 Direct F3, F5
transaction MUSA Performance Stock Unit Options Exercise $0 -14,600 -34% $0.000000 28,700 12 Feb 2025 Common Stock 14,600 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted Stock units that have vested and settled in shares of the Company's stock. Pursuant to the terms of the performance-based grant, the total includes 200% of the original award plus shares equivalent in value to accumulated dividends.
F2 Shares withheld for taxes on PSU vesting.
F3 Awarded under the 2023 Omnibus Incentive Plan
F4 The option vests in two equal installments, the first half two years after the grant date and the final half three years after the grant date.
F5 These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date.
F6 Award granted under the 2013 Long-Term Incentive Plan.